Skip to content

Conditioning Brain Responses to Improve Thigh Muscle Function After Anterior Cruciate Ligament Reconstruction

Operant Conditioning of Motor Evoked Responses to Improve Quadriceps Function in Individuals With Anterior Cruciate Ligament Reconstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03209531
Enrollment
11
Registered
2017-07-06
Start date
2017-09-21
Completion date
2025-11-24
Last updated
2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Injury

Keywords

Quadriceps activation deficits, ACL, Surgery, Quadrcieps weakness, Operant conditioning, Cortical excitability

Brief summary

The purpose of this study is to examine if thigh muscle weakness and the lack of muscle activation that accompanies ACL injury can be improved through a form of mental coaching and encouragement, known as operant conditioning.

Detailed description

Thigh muscle weakness is a common result after anterior cruciate ligament (ACL) injury and reconstruction surgery. Therefore, reducing thigh muscle weakness after ACL injury and reconstructive surgery is important as the quadriceps muscles act as shock absorbers that protect the knee joint. If significant weakness is present in the quadriceps, the knee is exposed to increased forces and often results in degeneration of the structures in the joint leading to osteoarthritis. Thus, it is important to investigate activation and strength rehabilitation methods for the quadriceps muscles. This research study is being done to learn if thigh muscle weakness and the lack of muscle activation that accompanies ACL injury can be improved by conditioning brain responses (elicited by non-invasive transcranial magnetic stimulation) using a form of training called as operant conditioning.

Interventions

Active encouragement and feedback to increase motor evoked response when stimulated.

BEHAVIORALControl

Absence of active encouragement and feedback to increase motor evoked response when stimulated.

DEVICESingle Pulse Transcranial Magnetic Stimulation

Transcranial magnetic stimulation to elicit a motor evoked response from the quadriceps muscles.

Sponsors

Medical University of South Carolina
CollaboratorOTHER
National Center of Neuromodulation for Rehabilitation
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* aged 18-45 years * suffered an acute, complete ACL rupture * have undergone ACL reconstructive surgery * willingness to participate in testing and follow-up as outlined in the protocol

Exclusion criteria

* have suffered a previous ACL injury; * have undergone previous major surgery to either knee; * have a history of recent significant knee injury (other than ACL) or lower-extremity fracture; * have a history of uncontrolled diabetes or hypertension; * be pregnant or plan to become pregnant; * have metal implants in the head; * have electronic devices in their ear or heart (e.g., cochlear implants or cardiac pacemakers); * have unexplained recurrent headaches; * have a recent history of seizures; * be taking drugs that reduce seizure threshold; * have a history of repeated fainting spells;

Design outcomes

Primary

MeasureTime frameDescription
Changes in Quadriceps muscle strengthApproximately 8 weeks after the start of interventionQuadriceps strength will be measured using an isokinetic dynamometer. Improvements in quadriceps strength from baseline to the end of intervention will be assessed and compared between groups.

Secondary

MeasureTime frameDescription
Changes in voluntary activationApproximately 8 weeks after the start of interventionVoluntary activation will be measured using an electrical superimposition technique. Improvements in voluntary activation from baseline to the end of intervention will be assessed and compared between groups.

Other

MeasureTime frameDescription
Changes in motor cortical excitability measuresApproximately after 8 weeks after the start of interventionMotor cortical excitability will be measured using single- and paired-pulse transcranial magnetic stimulation protocols. Improvements in motor cortical excitability from baseline to the end of intervention will be assessed and compared between groups.
Changes in Knee Injury and Osteoarthritis Outcome ScoreApproximately after 8 weeks after the start of interventionKnee Injury and Osteoarthritis Outcome Score (KOOS) will be measured using the KOOS questionnaire, which is a self-administered survey of knee function across five domains: pain, symptoms, activities of daily living, sport and recreation function, and knee related quality of life (scores range from 0 to 100, with 0 indicating extreme symptoms and 100 indicating no symptoms). The improvements in KOOS from baseline to the end of intervention will be assessed and compared between groups.
Changes in International Knee Documentation Committee ScoreApproximately after 8 weeks after the start of interventionInternational Knee Documentation Committee (IKDC) score will be measured using the IKDC subjective knee evaluation form, which is a survey of self-reported level of knee functioning across different domains (scores range from 0 to 100, with 0 indicating extreme symptoms and 100 indicating no symptoms).The improvements in IKDC score from baseline to the end of intervention will be assessed and compared between groups.
Changes in mid-point quadriceps muscle strengthApproximately 4 weeks after the start of intervention (mid-time point evaluation)Quadriceps strength will be measured using an isokinetic dynamometer. Improvements in quadriceps strength from baseline to the mid-point of intervention will be assessed and compared between groups.
Changes in Tegner Activity ScoreApproximately after 8 weeks after the start of interventionTegner activity score will be measured using the Tegner Activity level scale, which is a self-reported measure of activity level (scores range from 0 to 10, with 0 indicating no activity because of knee problems and 10 indicating extremely active in competitive sports). The improvements in Tegner activity score from baseline to the end of intervention will be assessed and compared between groups.
Changes in Marx Activity Rating ScoreApproximately after 8 weeks after the start of interventionMarx activity rating score will be measured using the Marx Activity Rating Scale, which is a self-reported rating scale designed to measure a subject's level of physical activity in four different categories: running, cutting, deceleration and pivoting (scores range from 0 to 16, with 0 indicating very low activity \[\< one time in a month\] because of knee problems and 16 indicating very high activity \[\> 4 times in a week\] in the four categories). The improvements in Marx activity score from baseline to the end of intervention will be assessed and compared between groups.
Changes in Lysholm Knee ScoreApproximately after 8 weeks after the start of interventionLysholm knee score will be measured using the Lysholm Knee Scoring Scale, which is a questionnaire that assesses knee function after conservatively or surgically treated knee ligament injuries based on activities that require knee movement (scores range from 0 to 100, with 0 indicating extreme symptoms and 100 indicating no symptoms). The improvements in Lysholm score from baseline to the end of intervention will be assessed and compared between groups.
Changes in mid-point voluntary activation as measured by percentage activation deficitApproximately 4 weeks after the start of intervention (mid-time point evaluation)Voluntary activation will be measured using an electrical superimposition technique. Improvements in voluntary activation from baseline to the mid-point of intervention will be assessed and compared between groups.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026